ResearcherCharles UniversityNo recent work listed

Jana Rychlíková

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6961-5260; OpenAlex author ID A5011079347. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2016: 1 paper

Papers 1

Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. Co-author DOI 10.3233/cbm-160617 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

M. Zeman · 1 shared paper, 2016 · strength 0.06
- Paper Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. DOI 10.3233/cbm-160617 ↗
Aleš Žák · 1 shared paper, 2016 · strength 0.06
- Paper Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. DOI 10.3233/cbm-160617 ↗
Marek Vecka · 1 shared paper, 2016 · strength 0.06
- Paper Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. DOI 10.3233/cbm-160617 ↗
Jaroslav Macášek · 1 shared paper, 2016 · strength 0.06
- Paper Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. DOI 10.3233/cbm-160617 ↗
T Krechler · 1 shared paper, 2016 · strength 0.06
- Paper Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. DOI 10.3233/cbm-160617 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.